Cargando…

miR-539 inhibits prostate cancer progression by directly targeting SPAG5

BACKGROUND: We conducted multiple microarray datasets analyses from clinical and xenograft tumor tissues to search for disease progression-driving oncogenes in prostate cancer (PCa). Sperm-associated antigen 5 (SPAG5) attracted our attention. SPAG5 was recently identified as an oncogene participatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hongtuan, Li, Shadan, Yang, Xiong, Qiao, Baomin, Zhang, Zhihong, Xu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818461/ https://www.ncbi.nlm.nih.gov/pubmed/27037000 http://dx.doi.org/10.1186/s13046-016-0337-8

Ejemplares similares

miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9
por: Sun, Qin Hui, et al.
Publicado: (2020)

miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion
por: Liu, Yanping, et al.
Publicado: (2017)

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression
por: Zhang, Hongtuan, et al.
Publicado: (2018)

Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer
por: Yu, Haibo, et al.
Publicado: (2019)

Overexpressed miR-539 exacerbates Pseudomonas aeruginosa puenmonia by promoting inflammatory responses
por: Li, Jianbo, et al.
Publicado: (2023)

Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma
por: Mirghasemi, Alireza, et al.
Publicado: (2015)

CircGNG4 Promotes the Progression of Prostate Cancer by Sponging miR-223 to Enhance EYA3/c-myc Expression
por: Xu, Shengxian, et al.
Publicado: (2021)

miR-539 activates the SAPK/JNK signaling pathway to promote ferropotosis in colorectal cancer by directly targeting TIPE
por: Yang, Yan, et al.
Publicado: (2021)

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018)

The effect of miR-539 regulating TRIAP1 on the apoptosis, proliferation, migration and invasion of osteosarcoma cells
por: Liu, Huowen, et al.
Publicado: (2021)

MiR-539-3p inhibited chondrogenic differentiation in human adipose stem cells by targeting Sox9
por: Qin, Feng, et al.
Publicado: (2022)

miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer
por: Guo, Jilong, et al.
Publicado: (2018)

Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma
por: Mirghasemi, Alireza, et al.
Publicado: (2016)

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
por: Zhang, Hongtuan, et al.
Publicado: (2015)

MiR-539-5p inhibits the inflammatory injury in septic H9c2 cells by regulating IRAK3
por: Hu, Xiaochen, et al.
Publicado: (2021)

CircFOXM1 promotes proliferation and metastasis of hepatocellular carcinoma via regulating miR-1179/SPAG5 axis
por: Wang, Gaoqing, et al.
Publicado: (2021)

SPAG5‐AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway
por: Xu, Jun, et al.
Publicado: (2020)

miR-539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2
por: Ye, Zhi-Hua, et al.
Publicado: (2018)

MiR-539-3p impairs osteogenesis by suppressing Wnt interaction with LRP-6 co-receptor and subsequent inhibition of Akap-3 signaling pathway
por: Tripathi, Alok, et al.
Publicado: (2022)

Long non-coding RNA LOC100129148 functions as an oncogene in human nasopharyngeal carcinoma by targeting miR-539-5p
por: Sun, Kai-Yu, et al.
Publicado: (2017)

LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR‐539
por: Nai, Yongjun, et al.
Publicado: (2019)

miR-539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1
por: Xue, Liang, et al.
Publicado: (2020)

LncRNA PCGEM1 contributes to malignant behaviors of glioma by regulating miR-539-5p/CDK6 axis
por: Liu, Shu-Li, et al.
Publicado: (2021)

MiR-539-5p negatively regulates migration of rMSCs induced by Bushen Huoxue decoction through targeting Wnt5a
por: Hu, Liuchao, et al.
Publicado: (2019)

MiR‐133a‐3p attenuates resistance of non‐small cell lung cancer cells to gefitinib by targeting SPAG5
por: Li, Qing, et al.
Publicado: (2021)

Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis
por: Saadatian, Zahra, et al.
Publicado: (2023)

miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020)

LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR-9-5p and regulating SPAG9 expression
por: Yan, Pei, et al.
Publicado: (2019)

miR-539-5p regulates Srebf1 transcription in the skeletal muscle of diabetic mice by targeting DNA methyltransferase 3b
por: Kesharwani, Devesh, et al.
Publicado: (2022)

miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1
por: Bai, Peide, et al.
Publicado: (2020)

Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress
por: Jiang, Xingkang, et al.
Publicado: (2016)

LncRNA H19 promotes the committed differentiation of stem cells from apical papilla via miR-141/SPAG9 pathway
por: Li, Zehan, et al.
Publicado: (2019)

A SNP-mediated lncRNA (LOC146880) and microRNA (miR-539-5p) interaction and its potential impact on the NSCLC risk
por: Feng, Tienan, et al.
Publicado: (2020)

miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma
por: Zhang, Chengshuo, et al.
Publicado: (2018)

LncRNA-XIST Promotes Proliferation and Migration in ox-LDL Stimulated Vascular Smooth Muscle Cells through miR-539-5p/SPP1 Axis
por: Zhang, Yi, et al.
Publicado: (2022)

miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
por: Chava, Srinivas, et al.
Publicado: (2019)

Suppression of ANT2 by miR-137 Inhibits Prostate Tumorigenesis
por: Zhang, Heyuan, et al.
Publicado: (2021)

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
por: Choi, Nahyun, et al.
Publicado: (2015)

lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC
por: Li, Zhixi, et al.
Publicado: (2020)

Long Noncoding RNA LINC00460 Modulates MMP-9 to Promote Cell Proliferation, Invasion and Apoptosis by Targeting miR-539 in Papillary Thyroid Cancer
por: Zou, Xian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0t6oh2svfndm39f4j9mu2m3mi